Page Content

Health Review

Before orientation, you're required to complete an occupational health assessment with Employee Health. This includes an occupational health history and assessment, immunization review, and tuberculosis screening.


Your occupational health assessment must be completed 14 days prior to your start date. Failure to complete your occupational health assessment in this time frame will delay your start date in the training program. Appointments fill up quickly. Schedule your appointment as soon as possible to avoid delays.

Attending MCSGME orientation, starting your training program, and all patient contact will be prohibited until up-to-date immunization records are documented and the pre-employment drug screen and tuberculosis testing have been completed and results have been documented.

As part of your onboarding process, you must complete a Virtual Post Offer Placement Assessment (POPA). Employee Occupational Health Services (EOHS) will be sending you an email with a link to process this assessment.

To ease and expedite your onboarding, you will submit your POPA forms electronically and have required POPA testing (urine drug screen, immunization titers and tuberculosis testing) performed at a location near you or at Mayo Clinic Florida campus. Please complete all the forms/steps within 2-3 days. EOHS will contact you to request additional information or to schedule required POPA testing.

If you have extenuating circumstances preventing any POPA testing during this time limit, or with other questions regarding the POPA process, please call EOHS Florida: (904) 953-2431 or email: Office hours are Monday-Friday between 6:30 a.m. and 4:30 p.m. Eastern Standard Time.

Required immunizations and tuberculosis testing

Medical questions about immunizations or tuberculosis should be directed to

New trainees are subject to the same requirements and process as Mayo Clinic employees regarding the vaccination policy as a condition of their appointment. Occupational Health Services will review immunization records of all incoming trainees as part of the MCSGME onboarding process. Exemption forms will be available to appointed trainees when the onboarding process begins (generally three to four months prior to program start).

Exemptions (if requested) must be submitted within two weeks of receipt of the onboarding package. All approvals of exemptions must be received before the first day the appointment begins or the appointment will be rescinded. In the event that an incoming trainee is part of a formal match agreement and elects not to be vaccinated or obtain an exemption prior to the program start date, Mayo Clinic will submit a request for waiver of the match agreement to rescind the appointment with the appropriate organization.

Vaccine description Vaccine requirement
Hepatitis B 
  • Documentation of a complete vaccine series
  • And documentation of blood tests (titers) showing immunity to Hepatitis B




  • Documentation of two doses of MMR vaccine after one year of age
  • Or documentation of blood tests (titers) showing immunity to Measles, Mumps, and Rubella
Varicella  Chicken Pox
  • Documentation of blood test (titer) showing immunity to the disease
  • Or documentation of two vaccines given 4 weeks apart
Tetanus Diptheria Pertussis Tdap
  • One time dose of Tdap with Td boosters every 10 years thereafter
  • As a condition of employment, Mayo Clinic requires all incoming trainees to be fully vaccinated for COVID-19, unless they obtain an approved exemption.
  • Incoming trainees will be required to have at least one dose of the vaccine prior to starting their program with a second dose scheduled, submit proof of previous vaccination, or obtain an exemption from Mayo Clinic.

Assessment of tuberculosis status 

Tuberculosis requirement 

Tuberculosis testing 

Negative QuantiFERON-TB blood test within the past six months

If you've had a positive TB blood test in the past, the following must be provided:

  • Documentation of negative chest x-ray taken within the past year
  • Documentation of treatment for latent TB, including medication name, dose, and duration